Articles citing this paper
Factors associated with the development of coronary artery disease in people with HIV
Ari S. Mushin A , Janine M. Trevillyan
B C * , Sue J. Lee A D , Anna C. Hearps A E and Jennifer F. Hoy A D
+ Author Affiliations
- Author Affiliations
A Department of Infectious Diseases, Monash University, Melbourne, Vic., Australia.
B Department of Infectious Diseases, Austin Health, Melbourne, Vic., Australia.
C Department of Infectious Diseases at the Peter Doherty Institute of Infection and Immunity, University of Melbourne, Melbourne, Vic., Australia.
D Department of Infectious Diseases, Alfred Hospital, Melbourne, Vic., Australia.
E Life Sciences Discipline, Burnet Institute, Melbourne, Vic., Australia.
Sexual Health 20(5) 470-474 https://doi.org/10.1071/SH23043
Submitted: 6 February 2023 Accepted: 13 June 2023 Published: 3 July 2023
1 articles found in Crossref database.
Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study
Mata Marín José Antonio,
Velasco-Penagos Juan Carlos,
Mauss Stefan,
Rodriguez-Evaristo Mara Soraya,
Pérez-Barragán Edgar,
Villa-Platas Joaquín,
Barragán-Huerta Laura, Gaytán-Martínez Jesús Enrique
International Journal of STD & AIDS. 2024 35(1). p.33
